Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer

被引:96
|
作者
Kim, Hye Jeong [1 ]
Kim, Na Kyung [1 ]
Choi, Ji Hun [1 ]
Sohn, Seo Young [1 ]
Kim, Se Won [1 ]
Jin, Sang-Man [1 ]
Jang, Hye Won [1 ]
Suh, Sunghwan [1 ]
Min, Yong-Ki [1 ]
Chung, Jae Hoon [1 ]
Kim, Sun Wook [1 ]
机构
[1] Sungkyunkwan Univ, Div Endocrinol & Metab, Dept Med, Samsung Med Ctr,Sch Med, 50 Irwon Dong, Seoul 135710, South Korea
关键词
ADIPONECTIN CONCENTRATIONS; RISK; OBESITY; CARCINOMA; LEPTIN; WEIGHT; MEN;
D O I
10.1111/j.1365-2265.2012.04506.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Epidemiological studies have demonstrated that excess weight increases the risk of thyroid cancer. However, the associations between excess weight and prognostic factors for thyroid cancer are uncertain. We evaluated the relationships between body mass index (BMI) and clinico-pathological features and outcomes of papillary thyroid cancer (PTC). Patients and Methods Retrospective analysis of 2057 patients with PTC was performed. Patients were grouped according to BMI (underweight, normal weight, overweight and obesity)-based World Health Organization standardized categories. Logistic regression models were used to assess the relationships between BMI and clinico-pathological features of PTC. A Cox proportional hazards model was used to examine the association between BMI and disease recurrence. Results A 5-kg/m2 increase in BMI was associated with PTC tumours larger than 1 cm [odds ratio (OR) 1.31, P < 0.001], with microscopic extrathyroidal invasion (OR 1.23, P = 0.006), and with advanced tumour-node-metastasis (TNM) stage (OR, 1.30, P = 0.003), which is independent of confounding variables such as gender, age, serum TSH, total cholesterol and fasting glucose level. The multivariate-adjusted OR [95% confidence intervals (CI)] in the overweight (25.029.9 kg/m2) and obese (BMI = 30) groups for tumours larger than 1 cm were 1.41 (1.101.81) and 2.17 (1.233.82), respectively, compared to the normal weight group (BMI 18.524.9). The multivariate-adjusted OR (95% CI) for microscopic extrathyroidal extension in the obesity group was 1.88 (1.063.32), and the OR for advanced TNM stage in the overweight group was 1.35 (1.021.79) compared to the normal weight group. During follow-up (median, 84 month; range, 1185), 43 patients (2.1%) experienced recurrence. There were no significant differences in recurrence of PTCs among BMI groups. Conclusions Higher BMI was strongly associated with larger tumour size, extrathyroidal invasion and advanced TNM stage of PTCs. However, there was no difference in recurrence rate among BMI groups. This study suggests that excess weight is associated with aggressive features of PTCs. Further studies with long-term follow-up are needed to confirm this finding.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [21] CLINICO-PATHOLOGICAL CHARACTERISTICS IN YOUNG AND ELDERLY PATIENTS WITH LUNG CANCER
    Arslan, Sulhattin
    Ozsahin, Sefa Levent
    Akkurt, Ibrahim
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2011, 14 (03): : 214 - 219
  • [22] Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features
    Durand, Stephanie
    Ferraro-Peyret, Carole
    Joufre, Mireille
    Chave, Annie
    Borson-Chazot, Francoise
    Selmi-Ruby, Samia
    Rousset, Bernard
    ENDOCRINE-RELATED CANCER, 2009, 16 (02) : 467 - 481
  • [23] Association between body mass index and aggressiveness of papillary thyroid carcinoma
    Faure, Eduardo N.
    Jimena Soutelo, Maria
    Clara Fritz, Maria
    Martin, Ayelen
    Musri, Yamile
    Lutfi, Ruben
    MEDICINA-BUENOS AIRES, 2018, 78 (03) : 145 - 150
  • [24] Clinico-pathological and molecular characterization of 9 cases of tall cell variant of papillary thyroid carcinoma
    Nechifor-Boila, A.
    Zahan, A.
    Banescu, C.
    Borda, A.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S101 - S102
  • [25] Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes
    Steinschneider, Miriam
    Pitaro, Jacob
    Koren, Shlomit
    Mizrakli, Yuval
    Benbassat, Carlos
    Muallem Kalmovich, Limor
    CANCERS, 2021, 13 (21)
  • [26] A clinico-pathological classification of cancer of the breast
    Raven, RW
    BRITISH MEDICAL JOURNAL, 1939, 1 : 611 - 613
  • [27] Ashy dermatosis: clinico-pathological associations in two cases
    Carboni, I.
    Costanzo, A.
    Campione, E.
    Paterno, E. J.
    Chimenti, S.
    CLINICA TERAPEUTICA, 2008, 159 (05): : 321 - 323
  • [28] Frequency and clinico-pathological associations of ras mutations in colorectal cancer in the Victorian population
    Thomas, RJS
    Liu, YS
    StClair, F
    Norris, PM
    Valentine, R
    Phillips, WA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1997, 67 (05): : 233 - 238
  • [29] Clinico-pathological pattern of thyroid disease treated surgically
    Shaikh, Abdul Ghani
    Bhutto, Afsar Ali
    Soomro, Quratulain
    Memon, Aijaz Ahmed
    RAWAL MEDICAL JOURNAL, 2014, 39 (04): : 406 - 410
  • [30] Prevalence of NTRK fusions and clinico-pathological characteristics of Middle Eastern papillary thyroid cancer revealed enrichment in BRAF wild-type PTC.
    Siraj, Abdul K.
    Bu, Rong
    Parvathareddy, Sandeep K.
    Kong, Yan
    Annaiyappanaidu, Padmanaban
    Ahmed, Saeeda O.
    Al-Rasheed, Maha
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2021, 81 (13)